SCHEMBL6403952

SCHEMBL6403952

O=[C]OCc1cc(=O)oc2cc(O)c(Br)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 6/20 0.49
AKR1B1 P15121 3/20 0.46
HSD17B3 P37058 4/20 0.44
KDM4E B2RXH2 6/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 5/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
GLA P06280 3/20 0.38
GAA P10253 3/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
GRB2 P62993 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14930073 0.83 HSD17B3 (0.63) MCL1AKR1B1HSD17B3KDM4ELMNA
SCHEMBL299767 0.82 MCL1 (0.50) MCL1AKR1B1HSD17B3KDM4ELMNA
SCHEMBL29806171 0.81 MCL1 (0.52) MCL1AKR1B1HSD17B3KDM4ELMNA
SCHEMBL299768 0.81 MCL1 (0.52) MCL1AKR1B1HSD17B3KDM4ELMNA
SCHEMBL6403956 0.81 MCL1 (0.49) MCL1AKR1B1HSD17B3KDM4ELMNA
SCHEMBL5336455 0.80 KDM4E (0.48) MCL1AKR1B1HSD17B3KDM4ELMNA
SCHEMBL7462235 0.80 MCL1 (0.76) MCL1AKR1B1HSD17B3KDM4EALDH1A1
SCHEMBL30350025 0.80 MCL1 (0.76) MCL1AKR1B1HSD17B3KDM4EALDH1A1
SCHEMBL17553159 0.80 MCL1 (0.57) MCL1AKR1B1HSD17B3KDM4EKMT2A
SCHEMBL13058664 0.80 HSD17B3 (0.58) MCL1AKR1B1HSD17B3KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9625448-B2 Double caged GABA compounds, bis-CNB-GABA THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-04-18 US claimed
US-20150266809-A1 DOUBLE CAGED GABA COMPOUNDS, BIS-CNB-GABA THE TRUSTEES OF PRINCETON UNIVERSITY 2015-09-24 US claimed
US-9625448-B2 Double caged GABA compounds, bis-CNB-GABA THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-04-18 US disclosed
US-20150266809-A1 DOUBLE CAGED GABA COMPOUNDS, BIS-CNB-GABA THE TRUSTEES OF PRINCETON UNIVERSITY 2015-09-24 US disclosed
US-20140256015-A1 CAGED COMPOUND WHICH CAN BE PHOTOACTIVATED SELECTIVELY FOR CELL TYPES TOHO UNIVERSITY (JP) 2014-09-11 US disclosed
US-20050232000-A1 Method of making information storage devices by molecular photolithography LINDSEY JONATHAN S 2005-10-20 US disclosed
WO-2004107407-A2 METHOD OF MAKING INFORMATION STORAGE DEVICES BY MOLECULAR PHOTOLITHOGRAPHY NORTH CAROLINA STATE UNIVERSITY (US) 2004-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266809-A1 DOUBLE CAGED GABA COMPOUNDS, BIS-CNB-GABA GABRB2, GABRB3, GABRB1 MCL1 3054/4885AKR1B1 2459/4885HSD17B3 2317/4885
US-20140256015-A1 CAGED COMPOUND WHICH CAN BE PHOTOACTIVATED SELECTIVELY FOR CELL TYPES CTSK, CTSF, TPX2 MCL1 3426/4885AKR1B1 3399/4885HSD17B3 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.